Alexander Hooftman

1.7k total citations · 1 hit paper
8 papers, 688 citations indexed

About

Alexander Hooftman is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Alexander Hooftman has authored 8 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 2 papers in Infectious Diseases. Recurrent topics in Alexander Hooftman's work include interferon and immune responses (4 papers), Inflammasome and immune disorders (4 papers) and Immune cells in cancer (2 papers). Alexander Hooftman is often cited by papers focused on interferon and immune responses (4 papers), Inflammasome and immune disorders (4 papers) and Immune cells in cancer (2 papers). Alexander Hooftman collaborates with scholars based in Ireland, United Kingdom and Switzerland. Alexander Hooftman's co-authors include Luke O'neill, Anne F. McGettrick, Peter F. Slivka, Kathy Banahan, Mark Hughes, Svenja Hester, Chris Ling, Sarah E. Corcoran, Marah C. Runtsch and Alan D. Irvine and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Cell Biology and Cell Metabolism.

In The Last Decade

Alexander Hooftman

8 papers receiving 686 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation

2020 406 citations Alexander Hooftman, Stefano Angiari et al. Cell Metabolism profile →

Peers

Alexander Hooftman

MB

IMMUN

EPIDE

ID

ONCOL

Liming Mao China

Chi G. Weindel United States

Louise H. Cengia Australia

Joshua S. Stoolman United States

Melanie Humphry United Kingdom

Loïc Rolas United Kingdom

Bradley N. Martin United States

Neelakshi R. Jog United States

Melanie R. Shakespear Australia

Pascal Devant United States

Liming Mao China

Alexander Hooftman

592 ×1.5

MB

299 ×0.9

IMMUN

108 ×1.6

EPIDE

49 ×0.9

ID

37 ×0.7

ONCOL

Citations per year, relative to Alexander Hooftman Alexander Hooftman (= 1×) peers Liming Mao

Countries citing papers authored by Alexander Hooftman

Since Specialization

Citations

This map shows the geographic impact of Alexander Hooftman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Hooftman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Hooftman more than expected).

Fields of papers citing papers by Alexander Hooftman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Hooftman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Hooftman. The network helps show where Alexander Hooftman may publish in the future.

Co-authorship network of co-authors of Alexander Hooftman

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Hooftman. A scholar is included among the top collaborators of Alexander Hooftman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Hooftman. Alexander Hooftman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Peace, Christian G., Juliana E. Toller-Kawahisa, Alexander Hooftman, et al.. (2024). Itaconate drives mtRNA-mediated type I interferon production through inhibition of succinate dehydrogenase. Nature Metabolism. 6(11). 2060–2069. 15 indexed citations

2.

Peace, Christian G., Alexander Hooftman, & Dylan G. Ryan. (2023). Inflammatory mitochondrial nucleic acids as drivers of pathophysiology. Clinical and Translational Medicine. 13(9). e1403–e1403. 3 indexed citations

3.

Ryan, Dylan G., Christian G. Peace, & Alexander Hooftman. (2023). Basic Mechanisms of Immunometabolites in Shaping the Immune Response. Journal of Innate Immunity. 15(1). 925–943. 9 indexed citations

4.

Hooftman, Alexander & Luke O'neill. (2021). Can NLRP3 inhibitors improve on dexamethasone for the treatment of COVID-19?. SHILAP Revista de lepidopterología. 2. 100048–100048. 4 indexed citations

5.

Zotta, Alessia, Alexander Hooftman, & Luke O'neill. (2021). SARS-CoV-2 targets MAVS for immune evasion. Nature Cell Biology. 23(7). 682–683. 17 indexed citations

6.

Hooftman, Alexander, Stefano Angiari, Svenja Hester, et al.. (2020). The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation. Cell Metabolism. 32(3). 468–478.e7. 406 indexed citations breakdown →

7.

Hooftman, Alexander & Luke O'neill. (2019). The Immunomodulatory Potential of the Metabolite Itaconate. Trends in Immunology. 40(8). 687–698. 155 indexed citations

8.

Horst, E, C J Meijer, Jacques J. M. van Dongen, et al.. (1990). Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development.. PubMed. 4(5). 383–9. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact